Open Menu
Topic: Analytical services

Insight & Resources

Whitepaper

Digital Transformation In Regulatory: Achieving Excellence Virtually

The COVID-19 pandemic demanded significant pivots in how life sciences professionals and regulators carried out their responsibilities. Remote working was imposed in many regions to minimize the spread of disease, so technology became critical for continued regulatory operations, including carrying out virtual inspections to assess drug safety and adherence to good manufacturing practices (GMP).